darifenacin and its Impurities

Darifenacin blocks M3 muscarinic acetylcholine receptors, which mediate bladder muscle contractions. It is a medication used to treat urinary incontinence.. Reference standards of Darifenacin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 31 results for darifenacin Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 31 25000

Darifenacin

Darifenacin


  • Catalogue No.:PA 31 25000

  • CAS :

    133099-04-4

  • Molecular Formula : C28H30N2O2

  • Molecular Weight : 426.55

Drug Reference Standards & Impurity Synthesis in India
PA STI 024370

rac Darifenacin-d4

rac Darifenacin-d4


  • Catalogue No.:PA STI 024370

  • CAS :

    1189701-43-6

  • Molecular Formula : C28H26D4N2O2

  • Molecular Weight : 430.57

Drug Reference Standards & Impurity Synthesis in India
PA STI 024380

(R)-Darifenacin-d4 Hydrobromide

(R)-Darifenacin-d4 Hydrobromide


  • Catalogue No.:PA STI 024380

  • CAS :

    1261394-25-5

  • Molecular Formula : C28H27D4BrN2O2

  • Molecular Weight : 511.49

Drug Reference Standards & Impurity Synthesis in India
PA STI 024381

Darifenacin-d4 Hydrobromide

Darifenacin-d4 Hydrobromide


  • Catalogue No.:PA STI 024381

  • CAS :

    NA

  • Molecular Formula : C28H27D4BrN2O2

  • Molecular Weight : 511.49

Drug Reference Standards & Impurity Synthesis in India
PA STI 024390

(R)​-​Darifenacin-d4

(R)​-​Darifenacin-d4


  • Catalogue No.:PA STI 024390

  • CAS :

    1261734-81-9

  • Molecular Formula : C28H26D4N2O2

  • Molecular Weight : 430.57

Drug Reference Standards & Impurity Synthesis in India
PA STI 050150

5-(2-Hydroxyethyl)-2,3-dihydrobenzofuran-d4

5-(2-Hydroxyethyl)-2,3-dihydrobenzofuran-d4


  • Catalogue No.:PA STI 050150

  • CAS :

    1185079-36-0

  • Molecular Formula : C10H8D4O2

  • Molecular Weight : 168.23

Drug Reference Standards & Impurity Synthesis in India
PA USP1164200

Darifenacin Hydrobromide (1164200)

Darifenacin Hydrobromide (1164200)


  • Catalogue No.:PA USP1164200

  • CAS :

    133099-07-7

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA USP1164222

Darifenacin Peak ID Mixture (A mixture consisting of Darifenacin Hydrobromide (99%), Dealkyl darife (1164222)

Darifenacin Peak ID Mixture (A mixture consisting of Darifenacin Hydrobromide (99%), Dealkyl darife (1164222)


  • Catalogue No.:PA USP1164222

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251000

α,α-Diphenyl-3-pyrrolidineacetamide

α,α-Diphenyl-3-pyrrolidineacetamide


  • Catalogue No.:PA 31 0251000

  • CAS :

    103887-32-7

  • Molecular Formula : C18H20N2O

  • Molecular Weight : 280.37

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251001

Darifenacin(acetic Acid) Des-(5-Ethyl-2,3-dihydrobenzofuran)

Darifenacin(acetic Acid) Des-(5-Ethyl-2,3-dihydrobenzofuran)


  • Catalogue No.:PA 31 0251001

  • CAS :

    1050646-75-7

  • Molecular Formula : C18H19NO2

  • Molecular Weight : 281.36

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251002

2,3-Dihydrobenzofuran-5-acetic Acid

2,3-Dihydrobenzofuran-5-acetic Acid


  • Catalogue No.:PA 31 0251002

  • CAS :

    69999-16-2

  • Molecular Formula : C10H10O3

  • Molecular Weight : 178.19

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251003

Darifenacin chiral peak identification mixture

Darifenacin chiral peak identification mixture


  • Catalogue No.:PA 31 0251003

  • CAS :

    NA

  • Molecular Formula : C28H31BrN2O2

  • Molecular Weight : 507.47

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251004

Darifenacin Hydrobromide, Dealkyl darifenacin, Ketodarifenacin and 7-Bromo darifenacin

Darifenacin Hydrobromide, Dealkyl darifenacin, Ketodarifenacin and 7-Bromo darifenacin


  • Catalogue No.:PA 31 0251004

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251005

2,3-Dihydro-5-benzofuranethanol

2,3-Dihydro-5-benzofuranethanol


  • Catalogue No.:PA 31 0251005

  • CAS :

    87776-76-9

  • Molecular Formula : C10H12O2

  • Molecular Weight : 164.2

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251006

(S)-N-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide

(S)-N-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide


  • Catalogue No.:PA 31 0251006

  • CAS :

    2280857-32-9

  • Molecular Formula : C38H40N2O3

  • Molecular Weight : 572.75

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251007

Tert-butyl 3-(cyanodiphenylmethyl)pyrrolidine-1-carboxylate

Tert-butyl 3-(cyanodiphenylmethyl)pyrrolidine-1-carboxylate


  • Catalogue No.:PA 31 0251007

  • CAS :

    1159977-31-7

  • Molecular Formula : C23H26N2O2

  • Molecular Weight : 362.47

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251008

Darifenacin 4-Hydroxy Impurity

Darifenacin 4-Hydroxy Impurity


  • Catalogue No.:PA 31 0251008

  • CAS :

    2468796-89-4

  • Molecular Formula : C28H31BrN2O2

  • Molecular Weight : 507.47

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251009

2-(1-(4-Hydroxy-3-(2-hydroxyethyl)phenethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide

2-(1-(4-Hydroxy-3-(2-hydroxyethyl)phenethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide


  • Catalogue No.:PA 31 0251009

  • CAS :

    206048-83-1

  • Molecular Formula : C28H32N2O3

  • Molecular Weight : 444.58

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251010

(S)-1-Tosylpyrrolidin-3-ol

(S)-1-Tosylpyrrolidin-3-ol


  • Catalogue No.:PA 31 0251010

  • CAS :

    943587-25-5

  • Molecular Formula : C11H15NO3S

  • Molecular Weight : 241.31

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251011

(S)-3-Benzhydryl-1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidine

(S)-3-Benzhydryl-1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidine


  • Catalogue No.:PA 31 0251011

  • CAS :

    1048979-15-2

  • Molecular Formula : C27H29NO

  • Molecular Weight : 383.54

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251012

(S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetonitrile oxalate

(S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetonitrile oxalate


  • Catalogue No.:PA 31 0251012

  • CAS :

    1207849-19-1

  • Molecular Formula : C20H20N2O4

  • Molecular Weight : 352.39

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251013

2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide

2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide


  • Catalogue No.:PA 31 0251013

  • CAS :

    133033-93-9

  • Molecular Formula : C28H30N2O2

  • Molecular Weight : 426.56

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251014

(S)-2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl-1,1,2,2-d4)pyrrolidin-3-yl)-2,2-diphenylacetamide

(S)-2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl-1,1,2,2-d4)pyrrolidin-3-yl)-2,2-diphenylacetamide


  • Catalogue No.:PA 31 0251014

  • CAS :

    1095598-84-7

  • Molecular Formula : C28H26D4N2O2

  • Molecular Weight : 430.58

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251015

3-(2-Amino-2-oxo-1,1-diphenylethyl)-1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidine 1-oxide

3-(2-Amino-2-oxo-1,1-diphenylethyl)-1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidine 1-oxide


  • Catalogue No.:PA 31 0251015

  • CAS :

    2416229-88-2

  • Molecular Formula : C28H30N2O3

  • Molecular Weight : 442.56

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251016

(S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetamide

(S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetamide


  • Catalogue No.:PA 31 0251016

  • CAS :

    134002-25-8

  • Molecular Formula : C18H20N2O

  • Molecular Weight : 280.37

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251017

(S)-N,N-bis(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-2,2-diphenyl-2-(pyrrolidin-3-yl)acetamide

(S)-N,N-bis(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-2,2-diphenyl-2-(pyrrolidin-3-yl)acetamide


  • Catalogue No.:PA 31 0251017

  • CAS :

    NA

  • Molecular Formula : C38H40N2O3

  • Molecular Weight : 572.75

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251018

(S)-1-Nitrosopyrrolidin-3-ol

(S)-1-Nitrosopyrrolidin-3-ol


  • Catalogue No.:PA 31 0251018

  • CAS :

    1341219-46-2

  • Molecular Formula : C4H8N2O2

  • Molecular Weight : 116.12

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251019

Darifenacin Cyano Pyrrolidine Nitroso Impurity

Darifenacin Cyano Pyrrolidine Nitroso Impurity


  • Catalogue No.:PA 31 0251019

  • CAS :

    NA

  • Molecular Formula : C18H17N3O

  • Molecular Weight : 291.35

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251020

Darifenacin Amide Nitroso Impurity

Darifenacin Amide Nitroso Impurity


  • Catalogue No.:PA 31 0251020

  • CAS :

    NA

  • Molecular Formula : C18H19N3O2

  • Molecular Weight : 309.37

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251021

N-(2-Aminophenyl)-N-methyl nitrous amide

N-(2-Aminophenyl)-N-methyl nitrous amide


  • Catalogue No.:PA 31 0251021

  • CAS :

    NA

  • Molecular Formula : C7H9N3O

  • Molecular Weight : 151.17

Drug Reference Standards & Impurity Synthesis in India
PA 31 0251022

Darifenacin R-Isomer Hydrochloride

Darifenacin R-Isomer Hydrochloride


  • Catalogue No.:PA 31 0251022

  • CAS :

    NA

  • Molecular Formula : C28H31ClN2O2

  • Molecular Weight : 463.02

pharmaffiliates